HIV 1 News and Research

RSS

IAS president will use AIDS 2012 to say 'thank you' to U.S. for contributions to HIV/AIDS battle

Elly Katabira, president of the International AIDS Society and co-chair of the 19th International AIDS Conference (AIDS 2012), said he will use the conference as an occasion to say "thank you" to the U.S., VOA News reports.

29 Jun 2012

HIV therapy: Interview with Joël Crouzet, CEO of InnaVirVax

HIV therapy has traditionally been associated with antiretrovirals, which considerably reduce the amount of virus present in the blood to nearly undetectable levels.

29 Jun 2012

Stanford Medical School comment on Supreme Court ruling on health-care reform law

Today’s Supreme Court ruling on the Patient Protection and Affordable Care Act of 2010 advances the broad effort to extend health-care coverage and control medical costs, though it raises questions about how certain provisions of the policy will be implemented, Stanford University School of Medicine experts said. Here are some initial comments on the court’s landmark decision.

29 Jun 2012

Once-daily pill for HIV is a safe and effective alternative to traditional antiretroviral regimens

A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week’s Lancet also indicate that the new “Quad” pill is faster acting, doesn’t have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.

29 Jun 2012

Gilead submits cobicistat NDA with FDA for treatment of HIV

Gilead Sciences, Inc. announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of cobicistat, a pharmacoenhancing or "boosting" agent that increases blood levels of certain commercially available protease inhibitors, including atazanavir and darunavir, in order to enable once-daily dosing.

29 Jun 2012

AHF urges Gilead to set initial price on latest HIV/AIDS drug combination

AIDS Healthcare Foundation (AHF) announced that California State Treasurer Bill Lockyer has sent a letter to California-based drug company, Gilead Sciences, Inc. urging the company to set an initial price on its latest HIV/AIDS drug combination—which is known as the 'Quad'—that is "…sensitive to ongoing state budget difficulties," and which will also "…provide the means to keep people with HIV/AIDS alive and as healthy as possible."

28 Jun 2012

Efforts to fight illegal drugs contributing to spread of HIV, report says

The Global Commission on Drug Policy (GCDP) on Tuesday published a report titled "The War on Drugs and HIV/AIDS: How the Criminalization of Drug Use Fuels the Global Pandemic," which "condemns the drug war as a failure and recommends immediate, major reforms of the global drug prohibition regime to halt the spread of HIV infection and other drug war harms," according to the report summary.

28 Jun 2012

Miriam Hospital receives NIH renewal grant to support growth of Lifespan/Tufts/Brown CFAR

The Miriam Hospital has received an $8.5 million, five-year renewal grant from the National Institutes of Health (NIH) to support the continued growth of the Lifespan/Tufts/Brown Center for AIDS Research (CFAR).

28 Jun 2012

Gay dads may experience lifestyle shifts that could reduce HIV risk

Gay parents face many of the same challenges as straight parents when it comes to sex and intimacy after having children, according to a new study of gay fathers published in the journal Couple and Family Psychology.

28 Jun 2012

Gilead submits elvitegravir NDA with FDA for treatment of HIV-1 infection

Gilead Sciences, Inc. announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced adults.

28 Jun 2012

Gates Foundation blog highlights work of CDC Kenya

In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, editor Amie Newman, a communications officer at the foundation, highlights the work of "two HIV home-visit health workers who work with the CDC Kenya (Centers for Disease Control) to visit with a family in a remote area in the Nyanza province."

27 Jun 2012

USA Today features Q&A on Truvada's potential as prevention tool

USA Today features a Q&A on Truvada, an antiretroviral drug that a Food and Drug Administration (FDA) panel in May recommended be approved for pre-exposure prophylaxis (PrEP) to prevent HIV among healthy people at risk of contracting the virus.

27 Jun 2012

Scientists discover new flu-fighting role for IL-15 protein

University of Georgia scientists have discovered a new flu-fighting role for a well-known component of the immune system. Kimberly Klonowski, assistant professor of cellular biology in the UGA Franklin College of Arts and Sciences, and her colleagues found that administering a cell-signaling protein known as IL-15 to mice infected with influenza reduces their peak viral load by nearly three times.

27 Jun 2012

U.S. Global AIDS Coordinator discusses lessons learned from U.S. response to HIV/AIDS worldwide

U.S. Global AIDS Coordinator Ambassador Eric Goosby "discussed lessons learned from the U.S. response to the global HIV/AIDS epidemic over the past decade at an event hosted by the Brookings Institute Monday morning," the Center for Global Health Policy's "Science Speaks" blog reports.

27 Jun 2012

VA encourages all veterans to be tested for HIV at least once in their life time

The Department of Veterans Affairs is encouraging all Veterans to be tested for HIV at least once in their lives.

27 Jun 2012

Link between bacterial vaginosis and female-to-male HIV transmission risk

An investigation led by UCSF has found that the risk of female-to-male HIV transmission is increased three fold for women with bacterial vaginosis, a common disorder in which the normal balance of bacteria in the vagina is disrupted.

27 Jun 2012

Nanoparticles that can slip through mucus barriers shown to protect against herpes infections

Johns Hopkins researchers say they have demonstrated, for the first time in animals, that nanoparticles can slip through mucus to deliver drugs directly to tissue surfaces in need of protection. The researchers used these mucus-penetrating particles (MPPs) to protect against vaginal herpes infections in mice and the goal is to create similar MPPs to deliver drugs that protect humans against sexually transmitted diseases or even treat cancer.

26 Jun 2012

Vatican official calls on international community to provide 'free, efficient' HIV treatment in Africa

Cardinal Tarcisio Bertone, the Vatican's secretary of state and number two official, "called Friday on the international community to provide 'free and efficient treatment' for AIDS in Africa, starting with pregnant women, mothers and their babies," Agence France-Presse reports.

26 Jun 2012

Beauty N Black Wellness Tour to improve health of African American families

In an effort to improve the health of African American families, the Beauty N Black Wellness Tour will turn beauty salons into centers for health information and screening, starting with a June 30th launch in Los Angeles.

26 Jun 2012

Combination regimens trump monotherapy in fight against HIV transmission

A two- or three-drug combination is more effective at reducing intrapartum HIV acquisition than zidovudine monotherapy in babies who are at high risk for transmission, a study in The New England Journal of Medicine shows.

25 Jun 2012

HIV 1 News and Research

IAS president will use AIDS 2012 to say 'thank you' to U.S. for contributions to HIV/AIDS battle

HIV therapy: Interview with Joël Crouzet, CEO of InnaVirVax

Stanford Medical School comment on Supreme Court ruling on health-care reform law

Once-daily pill for HIV is a safe and effective alternative to traditional antiretroviral regimens

Gilead submits cobicistat NDA with FDA for treatment of HIV

AHF urges Gilead to set initial price on latest HIV/AIDS drug combination

Efforts to fight illegal drugs contributing to spread of HIV, report says

Miriam Hospital receives NIH renewal grant to support growth of Lifespan/Tufts/Brown CFAR

Gay dads may experience lifestyle shifts that could reduce HIV risk

Gilead submits elvitegravir NDA with FDA for treatment of HIV-1 infection

Gates Foundation blog highlights work of CDC Kenya

USA Today features Q&A on Truvada's potential as prevention tool

Scientists discover new flu-fighting role for IL-15 protein

U.S. Global AIDS Coordinator discusses lessons learned from U.S. response to HIV/AIDS worldwide

VA encourages all veterans to be tested for HIV at least once in their life time

Link between bacterial vaginosis and female-to-male HIV transmission risk

Nanoparticles that can slip through mucus barriers shown to protect against herpes infections

Vatican official calls on international community to provide 'free, efficient' HIV treatment in Africa

Beauty N Black Wellness Tour to improve health of African American families

Combination regimens trump monotherapy in fight against HIV transmission

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News